Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

HeartBeam Inc. (NASDAQ: BEAT) Launches Study Focused on Testing Proprietary Patch Capable of Generating On-Demand 12-Lead ECG for Ischemia Detection

Coronary artery disease remains one of the most urgent and widespread health threats worldwide, contributing to millions of deaths each year and often progressing silently until a major cardiac event occurs. As healthcare providers search for faster and more accessible ways to identify high-risk patients earlier, HeartBeam (NASDAQ: BEAT) has launched a new pilot study […]

Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Identifies High-Priority Rare Earth Targets at Ontario’s Hopkins Project as Global Demand for Critical Minerals Accelerates

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF), a Canadian mineral exploration company focused on rare earth projects, has identified several priority exploration targets at its Hopkins Rare Earth Element Project in Ontario following completion of a comprehensive desktop study designed […]

MindWave Innovations Inc. (NYSE American: APUS) Is Building an Ecosystem Designed to Unlock the Full Potential of Digital Asset Treasury Management

Holding digital assets was once largely viewed as a passive strategy centered on long-term appreciation, inflation protection and portfolio diversification. Today, however, institutional investors are increasingly focused on a different objective: generating productive returns from digital asset holdings while maintaining the oversight, security and liquidity standards expected in traditional finance. That shift is driving growing […]

MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) Launches Lead Commercial Software Intox AI(TM) for Multiple Forms of Intoxication Detection

Disseminated on behalf of MindBio Therapeutics Corp. (CSE: MBIO) (OTCQB: MBQIF) and may include paid advertising. MindBio Therapeutics (CSE: MBIO) (OTCQB: MBQIF), a biotechnology company, has launched Intox AI(TM), its flagship enterprise software platform designed to detect drug use, alcohol intoxication, and human fatigue, through voice analysis powered by artificial intelligence. The announcement marks an […]

6th Chief Patient Officer Summit Returns to Boston to Focus on Patient-Centered Decisions and Development

Date: July 23-24, 2026 Venue: Boston, MA Dynamic Global Events (“DGE”) will host the 6th Chief Patient Officer Summit on July 23–24, 2026, at the Sheraton Boston Hotel in Boston, Massachusetts.  The 6th Chief Patient Officer Summit provides a unique opportunity to discuss in detail how organizations can better integrate patient perspectives into decision-making and […]

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Working to Help Employers Tackle Cardiovascular Risk, Healthcare Costs

A single heart attack or major cardiovascular event can have consequences that extend far beyond a patient’s health, affecting employers, insurers and healthcare systems through higher medical costs, lost productivity and long-term care expenses. As cardiovascular disease continues to drive a significant share of healthcare spending, organizations responsible for employee benefits are seeking new strategies […]

 

From Our Blog

VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC-ADC Platform as It Expands Next-Generation Cancer Therapy Pipeline

June 24, 2026

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has announced new in vitro proof-of-concept data supporting its BiTAC-ADC platform, a technology designed to improve the selectivity of antibody-drug conjugates in cancer treatment. The announcement comes as the company prepares to engage with potential pharmaceutical and biotechnology partners during the BIO International […]

Rotate your device 90° to view site.